Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations?

Kardiol Pol. 2024;82(1):7-9. doi: 10.33963/v.phj.98904. Epub 2024 Jan 17.
No abstract available

MeSH terms

  • Administration, Oral
  • Anticoagulants / adverse effects
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Hemorrhage / chemically induced
  • Hemorrhage / drug therapy
  • Humans
  • Risk Assessment
  • Risk Factors
  • Stroke* / drug therapy
  • Stroke* / etiology
  • Stroke* / prevention & control

Substances

  • Anticoagulants